Cancer 2035: A Roadmap for the Future
Co-hosted by the Milken Institute and the Richard Nixon Foundation, Cancer 2035: A Roadmap for the Future brings together leading oncologists, researchers, policymakers, and influential industry experts to examine how today’s scientific and technological capabilities can drive the next era of biomedical progress.
The event coincides with a pivotal milestone: the 55th anniversary of the National Cancer Act, landmark legislation that transformed the nation’s approach to cancer and set in motion decades of scientific and clinical progress.
Join health leaders as they discuss what it would take—in research, technology, policy, financing, and care delivery—to dramatically reduce cancer mortality by 2035.
Watch the Event Discussion
Program
February 23–24, 2026
The program will include fireside chats and panel discussions on:
The Next Decade of Defeating Cancer: Visions for What’s Possible
Prevention, Early Detection, and Interception
Designing the Clinical Trial Infrastructure of the Future
Mobilizing the Full Ecosystem: The Next Generation of Public–Private Partnerships
Accelerating the Future of Oncology
Technology as a Force Multiplier: Delivering Innovation at Scale
Speakers
Lucille Accetta
Chief Pharmacy Officer, CVS Health
Noubar Afeyan
CEO, Flagship Pioneering
Jim Allison
Nobel Laureate, Regental Chair and Professor of Immunology, MD Anderson Cancer Center
Margaret Anderson
Managing Partner, Deloitte
Charles Balch
President, International Society of Oncology Prevention and Treatment
Monica Bertagnolli
17th Director, National Institutes of Health
Luciana Borio
Venture Partner, ARCH Venture Partners
Shelley Moore Capito
US Senator, West Virginia
Chair, US Senate Appropriations Subcommittee on Department of Labor, HHS, and Education, and Related Agencies
Gina Carithers
President & CEO, Prostate Cancer Foundation
Francis Collins
16th Director, National Institutes of Health
Diana DeGette
US Representative, Colorado
Ranking Member, US House Energy and Commerce Subcommittee on Health
William Doyle
Executive Chairman, Novocure
Helmy Eltoukhy
Chairman and Co-CEO, Guardant Health
Melanie Eisenhower
Board Member, Richard Nixon Foundation
Andrew von Eschenbach
21st Commissioner, FDA; 12th Director, National Cancer Institute
David Fredrickson
Executive Vice President, AstraZeneca
Jackie Gerhart
Chief Medical Officer, Epic
Mark Goldsmith
CEO, Revolution Medicines
Marjorie Green
SVP, Head of Oncology, Merck
Leroy Hood
Co-founder, Institute for Systems Biology
Cliff Hudis
CEO, American Society of Clinical Oncology
Carl June
Professor of Immunotherapy, University of Pennsylvania Perelman School of Medicine
Edward Kim
Vice Physician-in-Chief, City of Hope National Medical Center
Karen Knudsen
CEO, Parker Institute for Cancer Immunotherapy
Pablo Legorreta
Founder, CEO, & Chairman, Royalty Pharma
Anthony Letai
Director, National Cancer Institute
Harlan Levine
President, Health Innovation and Policy, City of Hope
William Li
CEO, Angiogenesis Foundation
Joe Lopez
Acting President & CEO, Richard Nixon Foundation
Sharmila Makhija
Founding Dean & CEO, Alice L. Walton School of Medicine
Marlene Malek
Vice Chair and Co-Founder, Friends of Cancer Research
Mark McClellan
Director, Duke-Margolis Institute for Health Policy
Kimberly Myers
Principal, Deloitte
Prineha Narang
Professor in Physical Sciences and Electrical and Computer Engineering, UCLA
William Nelson
Director, Sidney Kimmel Comprehensive Cancer Center
Robert O'Brien
Chairman, Richard Nixon Foundation
Anaeze Offodile
Chief Strategy Officer, Memorial Sloan Kettering
Mehmet Oz
Administrator, Centers for Medicare & Medicaid Services
Richard Pazdur
Founding Director, Oncology Center of Excellence, FDA
Padmanee Sharma
Professor of Genitourinary Medical Oncology
Professor of Immunology, MD Anderson Cancer Center
Greg Simon
President, Simonovation; Founding Executive Director, FasterCures
Patrick Soon-Shiong
Founder, ImmunityBio
Jean-Charles Soria
Senior Vice President, Global Development Oncology, Amgen
Grant Verstandig
Founder, Chairman, and CEO, Red Cell Partners; Co-Founder and Executive Chairman at Zephyr A
George Yancopoulos
Co-founder, President, and Chief Scientific Officer, Regenero
Elias Zerhouni
15th Director, National Institutes of Health
Event Partner
- Image
Sponsors
- Image
- Image
- Image
- Image
- Image